消炎鎮痛剤および解熱剤の世界市場に関する洞察、2028年までの予測

Global Anti-Inflammatory Analgesic and Antipyretic Drugs Market Insights, Forecast to 2028

消炎鎮痛剤と解熱剤は、発熱した患者の体温を正常に戻すことができるが、正常な体温には影響を与えない。これらの薬も中程度の鎮痛作用があるが、モルヒネやその合成代用品ほどは強くない。一般に使用される解熱... もっと見る

出版社	出版年月	電子版価格	言語
QYResearch QYリサーチ	2022年9月2日	US$4,900 シングルユーザライセンスライセンス・価格情報注文方法はこちら	英語

※当ページの内容はウェブ更新時の情報です。
最新版の価格やページ数などの情報についてはお問合せください。
日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。

サマリー

消炎鎮痛剤と解熱剤は、発熱した患者の体温を正常に戻すことができるが、正常な体温には影響を与えない。これらの薬も中程度の鎮痛作用があるが、モルヒネやその合成代用品ほどは強くない。一般に使用される解熱鎮痛薬は、その化学構造からサリチル酸系、アニリン系、ピラゾロン系に分けられる。このうち、アニリン系以外は抗リウマチ作用があり、リウマチや関節リウマチの治療も可能です。

報告書の概要
COVID-19のパンデミックとロシア・ウクライナ戦争の影響により、2022年の製品名の世界市場は百万米ドルと推定され、2028年までに百万米ドルの改訂サイズに達し、予測期間2022-2028年にCAGR %で成長すると予測されます。
消炎鎮痛剤・解熱剤のアメリカ市場は、2023年から2028年の予測期間中にCAGR%で増加し、2022年の百万米ドルから2028年には百万米ドルに達すると予測されます。
消炎鎮痛剤・解熱剤の中国市場は、2023年から2028年の予測期間中にCAGR%で、2022年の100万ドルから2028年には100万ドルに達すると推定されます。
消炎鎮痛剤・解熱剤のヨーロッパ市場は、2023年から2028年の予測期間中にCAGR%で、2022年の百万ドルから2028年には百万ドルに達すると推定されます。
消炎鎮痛解熱薬の世界の主要メーカーは、Mallinckrodt Pharmaceuticals、IOL、Anqiu Lu'an Pharmaceutical、Novacyl、BASF、Anhui BBCA Pharmaceuticals、Hubei Biocause、Xinhua PharmおよびGranules India Limitedなどです。2021年、世界の上位5社は売上高で約 %のシェアを占めています。

レポート対象範囲
本最新レポートでは、産業構造、売上高、収益、価格、粗利率を調査しています。主要生産者の生産拠点、市場シェア、業界ランキング、プロフィールを掲載しています。最新の政府規制、市場情報、業界データにアクセスするため、一次調査および二次調査を実施しています。データは消炎鎮痛解熱剤メーカー、流通業者、エンドユーザー、業界団体、政府産業局、業界誌、業界専門家、第三者データベース、弊社内データベースから収集しました。
本レポートでは、各地域の消炎鎮痛解熱薬市場の主要企業に関する考察も行っています。さらに、世界の消炎鎮痛剤および解熱剤市場の主要な推進要因や地域別の力学、業界内の現行動向についても解説しています。

主な対象企業
本セクションでは、研究者は、事業を展開している著名なプレーヤーと、激しい競争に打ち勝つために彼らが焦点を当てている戦略について包括的な分析を行っています。また、著名なプレイヤーの会社概要と市場シェア分析もこのセクションで提供しています。さらに、専門家は、各プレイヤーの包括的な分析を行っています。彼らはまた、2017年から2022年の期間、メーカーの信頼性の高い売上高、収益、価格、市場シェアとランクデータを提供しています。本レポートの支援により、キープレイヤー、ステークホルダー、その他の参加者は、ビジネスにおける最近および今後の動向を把握することができ、さらに効率的な選択を行うことができるようになります。本調査レポートで取り上げた主要企業は以下の通りです。
マリンクロット・ファーマシューティカルズ
アイオーエル
安丘路安製薬
ノバシル
BASF
安徽省BBCA製薬
湖北省バイオコーズ
新華ファーマ
グラニュールスインディアリミテッド
華康製薬
河北智恒薬業
浙江康楽製薬
河北晶業医療技術有限公司
MSPF
洛安製薬
マリンクロッド
ファームソン
安徽富邦楼
SKPL
アタベイ
湖州コンチ製薬
安徽省トップスン
ソララ
SIグループ

市場セグメント
本レポートでは、主要セグメントである「タイプ別」「アプリケーション別」について調査しています。本レポートでは、業界の専門家により、その有利性と成長の可能性が検討されています。また、本レポートでは、2017-2028年までの売上高、収益、平均価格の予測データを、タイプ別、アプリケーション別セグメントに基づいて掲載しています。
消炎鎮痛解熱剤のタイプ別セグメント
パラセタモール
アスピリン
イブプロフェン
ナプロキセン
ジクロフェナク
オキサプロジン
デキシブプロフェン
その他
消炎鎮痛剤・解熱剤の用途別構成比
成人
小児

主要地域と国
本セクションでは、様々な地域と各地域で活動する主要企業に関する主要な洞察を提供します。特定の地域/国の成長を評価する際に、経済的、社会的、環境的、技術的、政治的な要因が考慮されています。また、読者は2017-2028年までの各地域・国の金額と売上高データを手にすることができます。
北アメリカ
米国
カナダ
欧州
ドイツ
フランス
英国
イタリア
ロシア
アジア太平洋地域
中国
日本
韓国
インド
オーストラリア
中国台湾
インドネシア
タイ
マレーシア
中南米
メキシコ
ブラジル
アルゼンチン
コロンビア
中東・アフリカ
トルコ
サウジアラビア
UAE

主要なドライバーと障壁
本レポートでは、読者が一般的な開発を理解するのに役立つように、影響の大きいレンダリング要因とドライバーを調査しています。さらに、このレポートには、プレイヤーの道を阻むブロックとして機能する可能性のある抑制と課題も含まれています。これは、ユーザーが気を配り、ビジネスに関連する情報に基づいた意思決定を行うために支援します。専門家はまた、今後のビジネスの展望に彼らの焦点を置いています。
COVID-19とロシア・ウクライナ戦争影響力分析
このセクションの読者は、抗炎症鎮痛解熱薬市場のシナリオがパンデミック、ポストパンデミック、ロシア・ウクライナ戦争中に世界中でどのように変化したかを理解することができます。本調査は、需要、消費、輸送、消費者行動、サプライチェーン管理、輸出入、生産などの側面における変化を視野に入れて行われます。また、業界の専門家は、今後数年間でプレイヤーに機会を創出し、業界全体を安定させるのに役立つ主要な要因を取り上げています。

レポートには以下の内容が含まれます。
消炎鎮痛解熱薬の世界市場概要、売上、収益、価格などをまとめたレポートです。2017年～2021年の歴史的な市場収益/売上データ、2022年の予測、2028年までのCAGRの予測により、世界市場の動向を分析します。
本レポートでは、消炎鎮痛剤および解熱剤の主要生産者を調査し、主要地域と国の売上高も掲載しています。消炎鎮痛剤および解熱剤の今後の市場可能性のハイライトと、この市場を様々なセグメントとサブセグメントに分けて予測するための主要地域/国別の注目点。米国、カナダ、メキシコ、ブラジル、中国、日本、韓国、東南アジア、インド、ドイツ、英国、イタリア、中東、アフリカ、その他の国々の国別データおよび市場価値分析。

本レポートでは、2017年から2022年までのデータから、主要メーカーの消炎鎮痛解熱剤の売上、収益、市場シェア、業界ランキングに焦点をあてています。世界の消炎鎮痛剤および解熱剤市場における主要なステークホルダーの特定、および最近の開発状況やセグメント別の収益に基づく競争環境と市場ポジショニングの分析。本レポートは、利害関係者が競争環境を理解し、より多くの洞察を得て、ビジネスと市場戦略をより良い方法で位置づけるのに役立ちます。

本レポートでは、2017年から2028年までのタイプ別、用途別のセグメントデータ、売上高、収益、価格を分析しています。消炎鎮痛解熱薬の売上、予測成長動向、生産技術、用途、エンドユーザー業界の市場規模を評価・予測。
Mallinckrodt Pharmaceuticals、IOL、Anqiu Lu'an Pharmaceutical、Novacyl、BASF、Anhui BBCA Pharmaceuticals、Hubei Biocause、Xinhua Pharm and Granules India Limitedなど、世界の主要企業の説明的企業プロファイル。

章の概要
第1章：レポートのスコープ、各市場セグメント（製品タイプ、アプリケーションなど）の市場規模、将来の発展可能性などのエグゼクティブサマリーを紹介します。市場の現状と、短中期および長期的な展開の可能性を高次元で把握できます。
第2章：消炎鎮痛剤・解熱剤の売上（消費）、収益（世界レベル、地域レベル、国レベル）。各地域と主要国の市場規模と発展可能性を定量的に分析し、世界各国の市場発展、今後の発展展望、市場スペース、生産能力などを紹介しています。
第3章消炎鎮痛剤・解熱剤メーカーの競争環境、価格、売上高、市場シェア、業界ランキング、最新の開発計画、M&A情報などを詳細に分析。
第4章：製品タイプによる様々な市場セグメントの分析を提供し、各市場セグメントの売上高、収益、平均価格、発展の可能性を網羅し、読者が異なる市場セグメントでブルーオーシャン市場を見つけるのに役立ちます。
第5章：読者が異なる下流市場のブルーオーシャン市場を見つけるのを助けるために、アプリケーションに応じて様々な市場セグメントの分析、各市場セグメントの売上高、収益、平均価格、および開発ポテンシャルをカバーすることを提供します。
第6章：北米：タイプ別、用途別、国別、セグメント別の売上高と収益。
第7章：ヨーロッパ：タイプ別、アプリケーション別、国別、セグメント別の売上高と収益。
第8章：アジア太平洋：タイプ別、アプリケーション別、国別、セグメント別の売上高と収益。
第9章：中南米：タイプ別、アプリケーション別、国別、セグメント別の売上高と収益。
第10章：中東・アフリカ：タイプ別、アプリケーション別、国別、セグメント別の売上高と収益。
第11章：主要メーカーのプロフィールを提供、製品説明や仕様、消炎鎮痛剤・解熱剤の売上、収益、価格、粗利、最近の開発など、市場の主要企業の基本状況を詳細に紹介。
第12章：産業チェーン、販売チャネル、主要原材料、流通業者、顧客に関する分析。
第13章：市場力学、市場の最新動向、市場の推進要因と制限要因、業界のメーカーが直面する課題とリスク、業界の関連政策の分析などを紹介します。
第14章：レポートの要点と結論。

ページTOPに戻る

1 Study Coverage
1.1 Anti-Inflammatory Analgesic and Antipyretic Drugs Product Introduction
1.2 Market by Type
1.2.1 Global Anti-Inflammatory Analgesic and Antipyretic Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Paracetamol
1.2.3 Aspirin
1.2.4 Ibuprofen
1.2.5 Naproxen
1.2.6 Diclofenac
1.2.7 Oxaprozin
1.2.8 Dexibuprofen
1.2.9 Others
1.3 Market by Application
1.3.1 Global Anti-Inflammatory Analgesic and Antipyretic Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Adults
1.3.3 Children
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Anti-Inflammatory Analgesic and Antipyretic Drugs Sales Estimates and Forecasts 2017-2028
2.2 Global Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue Estimates and Forecasts 2017-2028
2.3 Global Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Anti-Inflammatory Analgesic and Antipyretic Drugs Sales by Region
2.4.1 Global Anti-Inflammatory Analgesic and Antipyretic Drugs Sales by Region (2017-2022)
2.4.2 Global Sales Anti-Inflammatory Analgesic and Antipyretic Drugs by Region (2023-2028)
2.5 Global Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue by Region
2.5.1 Global Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue by Region (2017-2022)
2.5.2 Global Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Anti-Inflammatory Analgesic and Antipyretic Drugs Sales by Manufacturers
3.1.1 Global Top Anti-Inflammatory Analgesic and Antipyretic Drugs Manufacturers by Sales (2017-2022)
3.1.2 Global Anti-Inflammatory Analgesic and Antipyretic Drugs Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Anti-Inflammatory Analgesic and Antipyretic Drugs in 2021
3.2 Global Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue by Manufacturers
3.2.1 Global Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue by Manufacturers (2017-2022)
3.2.2 Global Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue in 2021
3.3 Global Anti-Inflammatory Analgesic and Antipyretic Drugs Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Anti-Inflammatory Analgesic and Antipyretic Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Anti-Inflammatory Analgesic and Antipyretic Drugs Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Anti-Inflammatory Analgesic and Antipyretic Drugs Sales by Type
4.1.1 Global Anti-Inflammatory Analgesic and Antipyretic Drugs Historical Sales by Type (2017-2022)
4.1.2 Global Anti-Inflammatory Analgesic and Antipyretic Drugs Forecasted Sales by Type (2023-2028)
4.1.3 Global Anti-Inflammatory Analgesic and Antipyretic Drugs Sales Market Share by Type (2017-2028)
4.2 Global Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue by Type
4.2.1 Global Anti-Inflammatory Analgesic and Antipyretic Drugs Historical Revenue by Type (2017-2022)
4.2.2 Global Anti-Inflammatory Analgesic and Antipyretic Drugs Forecasted Revenue by Type (2023-2028)
4.2.3 Global Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue Market Share by Type (2017-2028)
4.3 Global Anti-Inflammatory Analgesic and Antipyretic Drugs Price by Type
4.3.1 Global Anti-Inflammatory Analgesic and Antipyretic Drugs Price by Type (2017-2022)
4.3.2 Global Anti-Inflammatory Analgesic and Antipyretic Drugs Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Anti-Inflammatory Analgesic and Antipyretic Drugs Sales by Application
5.1.1 Global Anti-Inflammatory Analgesic and Antipyretic Drugs Historical Sales by Application (2017-2022)
5.1.2 Global Anti-Inflammatory Analgesic and Antipyretic Drugs Forecasted Sales by Application (2023-2028)
5.1.3 Global Anti-Inflammatory Analgesic and Antipyretic Drugs Sales Market Share by Application (2017-2028)
5.2 Global Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue by Application
5.2.1 Global Anti-Inflammatory Analgesic and Antipyretic Drugs Historical Revenue by Application (2017-2022)
5.2.2 Global Anti-Inflammatory Analgesic and Antipyretic Drugs Forecasted Revenue by Application (2023-2028)
5.2.3 Global Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue Market Share by Application (2017-2028)
5.3 Global Anti-Inflammatory Analgesic and Antipyretic Drugs Price by Application
5.3.1 Global Anti-Inflammatory Analgesic and Antipyretic Drugs Price by Application (2017-2022)
5.3.2 Global Anti-Inflammatory Analgesic and Antipyretic Drugs Price Forecast by Application (2023-2028)
6 North America
6.1 North America Anti-Inflammatory Analgesic and Antipyretic Drugs Market Size by Type
6.1.1 North America Anti-Inflammatory Analgesic and Antipyretic Drugs Sales by Type (2017-2028)
6.1.2 North America Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue by Type (2017-2028)
6.2 North America Anti-Inflammatory Analgesic and Antipyretic Drugs Market Size by Application
6.2.1 North America Anti-Inflammatory Analgesic and Antipyretic Drugs Sales by Application (2017-2028)
6.2.2 North America Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue by Application (2017-2028)
6.3 North America Anti-Inflammatory Analgesic and Antipyretic Drugs Market Size by Country
6.3.1 North America Anti-Inflammatory Analgesic and Antipyretic Drugs Sales by Country (2017-2028)
6.3.2 North America Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Anti-Inflammatory Analgesic and Antipyretic Drugs Market Size by Type
7.1.1 Europe Anti-Inflammatory Analgesic and Antipyretic Drugs Sales by Type (2017-2028)
7.1.2 Europe Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue by Type (2017-2028)
7.2 Europe Anti-Inflammatory Analgesic and Antipyretic Drugs Market Size by Application
7.2.1 Europe Anti-Inflammatory Analgesic and Antipyretic Drugs Sales by Application (2017-2028)
7.2.2 Europe Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue by Application (2017-2028)
7.3 Europe Anti-Inflammatory Analgesic and Antipyretic Drugs Market Size by Country
7.3.1 Europe Anti-Inflammatory Analgesic and Antipyretic Drugs Sales by Country (2017-2028)
7.3.2 Europe Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Anti-Inflammatory Analgesic and Antipyretic Drugs Market Size by Type
8.1.1 Asia Pacific Anti-Inflammatory Analgesic and Antipyretic Drugs Sales by Type (2017-2028)
8.1.2 Asia Pacific Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue by Type (2017-2028)
8.2 Asia Pacific Anti-Inflammatory Analgesic and Antipyretic Drugs Market Size by Application
8.2.1 Asia Pacific Anti-Inflammatory Analgesic and Antipyretic Drugs Sales by Application (2017-2028)
8.2.2 Asia Pacific Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue by Application (2017-2028)
8.3 Asia Pacific Anti-Inflammatory Analgesic and Antipyretic Drugs Market Size by Region
8.3.1 Asia Pacific Anti-Inflammatory Analgesic and Antipyretic Drugs Sales by Region (2017-2028)
8.3.2 Asia Pacific Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Anti-Inflammatory Analgesic and Antipyretic Drugs Market Size by Type
9.1.1 Latin America Anti-Inflammatory Analgesic and Antipyretic Drugs Sales by Type (2017-2028)
9.1.2 Latin America Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue by Type (2017-2028)
9.2 Latin America Anti-Inflammatory Analgesic and Antipyretic Drugs Market Size by Application
9.2.1 Latin America Anti-Inflammatory Analgesic and Antipyretic Drugs Sales by Application (2017-2028)
9.2.2 Latin America Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue by Application (2017-2028)
9.3 Latin America Anti-Inflammatory Analgesic and Antipyretic Drugs Market Size by Country
9.3.1 Latin America Anti-Inflammatory Analgesic and Antipyretic Drugs Sales by Country (2017-2028)
9.3.2 Latin America Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
9.3.6 Colombia
10 Middle East and Africa
10.1 Middle East and Africa Anti-Inflammatory Analgesic and Antipyretic Drugs Market Size by Type
10.1.1 Middle East and Africa Anti-Inflammatory Analgesic and Antipyretic Drugs Sales by Type (2017-2028)
10.1.2 Middle East and Africa Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue by Type (2017-2028)
10.2 Middle East and Africa Anti-Inflammatory Analgesic and Antipyretic Drugs Market Size by Application
10.2.1 Middle East and Africa Anti-Inflammatory Analgesic and Antipyretic Drugs Sales by Application (2017-2028)
10.2.2 Middle East and Africa Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue by Application (2017-2028)
10.3 Middle East and Africa Anti-Inflammatory Analgesic and Antipyretic Drugs Market Size by Country
10.3.1 Middle East and Africa Anti-Inflammatory Analgesic and Antipyretic Drugs Sales by Country (2017-2028)
10.3.2 Middle East and Africa Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Mallinckrodt Pharmaceuticals
11.1.1 Mallinckrodt Pharmaceuticals Corporation Information
11.1.2 Mallinckrodt Pharmaceuticals Overview
11.1.3 Mallinckrodt Pharmaceuticals Anti-Inflammatory Analgesic and Antipyretic Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Mallinckrodt Pharmaceuticals Anti-Inflammatory Analgesic and Antipyretic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Mallinckrodt Pharmaceuticals Recent Developments
11.2 IOL
11.2.1 IOL Corporation Information
11.2.2 IOL Overview
11.2.3 IOL Anti-Inflammatory Analgesic and Antipyretic Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 IOL Anti-Inflammatory Analgesic and Antipyretic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 IOL Recent Developments
11.3 Anqiu Lu'an Pharmaceutical
11.3.1 Anqiu Lu'an Pharmaceutical Corporation Information
11.3.2 Anqiu Lu'an Pharmaceutical Overview
11.3.3 Anqiu Lu'an Pharmaceutical Anti-Inflammatory Analgesic and Antipyretic Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Anqiu Lu'an Pharmaceutical Anti-Inflammatory Analgesic and Antipyretic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Anqiu Lu'an Pharmaceutical Recent Developments
11.4 Novacyl
11.4.1 Novacyl Corporation Information
11.4.2 Novacyl Overview
11.4.3 Novacyl Anti-Inflammatory Analgesic and Antipyretic Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Novacyl Anti-Inflammatory Analgesic and Antipyretic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Novacyl Recent Developments
11.5 BASF
11.5.1 BASF Corporation Information
11.5.2 BASF Overview
11.5.3 BASF Anti-Inflammatory Analgesic and Antipyretic Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 BASF Anti-Inflammatory Analgesic and Antipyretic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 BASF Recent Developments
11.6 Anhui BBCA Pharmaceuticals
11.6.1 Anhui BBCA Pharmaceuticals Corporation Information
11.6.2 Anhui BBCA Pharmaceuticals Overview
11.6.3 Anhui BBCA Pharmaceuticals Anti-Inflammatory Analgesic and Antipyretic Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Anhui BBCA Pharmaceuticals Anti-Inflammatory Analgesic and Antipyretic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Anhui BBCA Pharmaceuticals Recent Developments
11.7 Hubei Biocause
11.7.1 Hubei Biocause Corporation Information
11.7.2 Hubei Biocause Overview
11.7.3 Hubei Biocause Anti-Inflammatory Analgesic and Antipyretic Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Hubei Biocause Anti-Inflammatory Analgesic and Antipyretic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Hubei Biocause Recent Developments
11.8 Xinhua Pharm
11.8.1 Xinhua Pharm Corporation Information
11.8.2 Xinhua Pharm Overview
11.8.3 Xinhua Pharm Anti-Inflammatory Analgesic and Antipyretic Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Xinhua Pharm Anti-Inflammatory Analgesic and Antipyretic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Xinhua Pharm Recent Developments
11.9 Granules India Limited
11.9.1 Granules India Limited Corporation Information
11.9.2 Granules India Limited Overview
11.9.3 Granules India Limited Anti-Inflammatory Analgesic and Antipyretic Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Granules India Limited Anti-Inflammatory Analgesic and Antipyretic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Granules India Limited Recent Developments
11.10 Huagang Pharm
11.10.1 Huagang Pharm Corporation Information
11.10.2 Huagang Pharm Overview
11.10.3 Huagang Pharm Anti-Inflammatory Analgesic and Antipyretic Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Huagang Pharm Anti-Inflammatory Analgesic and Antipyretic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Huagang Pharm Recent Developments
11.11 Hebei Jiheng Pharmaceutical
11.11.1 Hebei Jiheng Pharmaceutical Corporation Information
11.11.2 Hebei Jiheng Pharmaceutical Overview
11.11.3 Hebei Jiheng Pharmaceutical Anti-Inflammatory Analgesic and Antipyretic Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Hebei Jiheng Pharmaceutical Anti-Inflammatory Analgesic and Antipyretic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Hebei Jiheng Pharmaceutical Recent Developments
11.12 Zhejiang Kangle Pharmaceutical
11.12.1 Zhejiang Kangle Pharmaceutical Corporation Information
11.12.2 Zhejiang Kangle Pharmaceutical Overview
11.12.3 Zhejiang Kangle Pharmaceutical Anti-Inflammatory Analgesic and Antipyretic Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Zhejiang Kangle Pharmaceutical Anti-Inflammatory Analgesic and Antipyretic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Zhejiang Kangle Pharmaceutical Recent Developments
11.13 Hebei Jingye Medical Technology
11.13.1 Hebei Jingye Medical Technology Corporation Information
11.13.2 Hebei Jingye Medical Technology Overview
11.13.3 Hebei Jingye Medical Technology Anti-Inflammatory Analgesic and Antipyretic Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Hebei Jingye Medical Technology Anti-Inflammatory Analgesic and Antipyretic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Hebei Jingye Medical Technology Recent Developments
11.14 MSPF
11.14.1 MSPF Corporation Information
11.14.2 MSPF Overview
11.14.3 MSPF Anti-Inflammatory Analgesic and Antipyretic Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 MSPF Anti-Inflammatory Analgesic and Antipyretic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 MSPF Recent Developments
11.15 Lu'an Pharmaceutical
11.15.1 Lu'an Pharmaceutical Corporation Information
11.15.2 Lu'an Pharmaceutical Overview
11.15.3 Lu'an Pharmaceutical Anti-Inflammatory Analgesic and Antipyretic Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.15.4 Lu'an Pharmaceutical Anti-Inflammatory Analgesic and Antipyretic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Lu'an Pharmaceutical Recent Developments
11.16 Mallinckrodt
11.16.1 Mallinckrodt Corporation Information
11.16.2 Mallinckrodt Overview
11.16.3 Mallinckrodt Anti-Inflammatory Analgesic and Antipyretic Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.16.4 Mallinckrodt Anti-Inflammatory Analgesic and Antipyretic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 Mallinckrodt Recent Developments
11.17 Farmson
11.17.1 Farmson Corporation Information
11.17.2 Farmson Overview
11.17.3 Farmson Anti-Inflammatory Analgesic and Antipyretic Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.17.4 Farmson Anti-Inflammatory Analgesic and Antipyretic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.17.5 Farmson Recent Developments
11.18 Anhui Fubore
11.18.1 Anhui Fubore Corporation Information
11.18.2 Anhui Fubore Overview
11.18.3 Anhui Fubore Anti-Inflammatory Analgesic and Antipyretic Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.18.4 Anhui Fubore Anti-Inflammatory Analgesic and Antipyretic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.18.5 Anhui Fubore Recent Developments
11.19 SKPL
11.19.1 SKPL Corporation Information
11.19.2 SKPL Overview
11.19.3 SKPL Anti-Inflammatory Analgesic and Antipyretic Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.19.4 SKPL Anti-Inflammatory Analgesic and Antipyretic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.19.5 SKPL Recent Developments
11.20 Atabay
11.20.1 Atabay Corporation Information
11.20.2 Atabay Overview
11.20.3 Atabay Anti-Inflammatory Analgesic and Antipyretic Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.20.4 Atabay Anti-Inflammatory Analgesic and Antipyretic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.20.5 Atabay Recent Developments
11.21 Huzhou Konch Pharmaceutical
11.21.1 Huzhou Konch Pharmaceutical Corporation Information
11.21.2 Huzhou Konch Pharmaceutical Overview
11.21.3 Huzhou Konch Pharmaceutical Anti-Inflammatory Analgesic and Antipyretic Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.21.4 Huzhou Konch Pharmaceutical Anti-Inflammatory Analgesic and Antipyretic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.21.5 Huzhou Konch Pharmaceutical Recent Developments
11.22 Anhui Topsun
11.22.1 Anhui Topsun Corporation Information
11.22.2 Anhui Topsun Overview
11.22.3 Anhui Topsun Anti-Inflammatory Analgesic and Antipyretic Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.22.4 Anhui Topsun Anti-Inflammatory Analgesic and Antipyretic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.22.5 Anhui Topsun Recent Developments
11.23 SOLARA
11.23.1 SOLARA Corporation Information
11.23.2 SOLARA Overview
11.23.3 SOLARA Anti-Inflammatory Analgesic and Antipyretic Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.23.4 SOLARA Anti-Inflammatory Analgesic and Antipyretic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.23.5 SOLARA Recent Developments
11.24 SI Group
11.24.1 SI Group Corporation Information
11.24.2 SI Group Overview
11.24.3 SI Group Anti-Inflammatory Analgesic and Antipyretic Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.24.4 SI Group Anti-Inflammatory Analgesic and Antipyretic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.24.5 SI Group Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Anti-Inflammatory Analgesic and Antipyretic Drugs Industry Chain Analysis
12.2 Anti-Inflammatory Analgesic and Antipyretic Drugs Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Anti-Inflammatory Analgesic and Antipyretic Drugs Production Mode & Process
12.4 Anti-Inflammatory Analgesic and Antipyretic Drugs Sales and Marketing
12.4.1 Anti-Inflammatory Analgesic and Antipyretic Drugs Sales Channels
12.4.2 Anti-Inflammatory Analgesic and Antipyretic Drugs Distributors
12.5 Anti-Inflammatory Analgesic and Antipyretic Drugs Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Anti-Inflammatory Analgesic and Antipyretic Drugs Industry Trends
13.2 Anti-Inflammatory Analgesic and Antipyretic Drugs Market Drivers
13.3 Anti-Inflammatory Analgesic and Antipyretic Drugs Market Challenges
13.4 Anti-Inflammatory Analgesic and Antipyretic Drugs Market Restraints
14 Key Findings in The Global Anti-Inflammatory Analgesic and Antipyretic Drugs Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

ページTOPに戻る

Table of Contents

Summary

Anti-Inflammatory Analgesic and Antipyretic Drug can make the body temperature of a febrile patient return to normal, but have no effect on normal body temperature. These drugs also have moderate analgesic effects, but not as strong as morphine and its synthetic substitutes. Commonly used antipyretic and analgesic drugs can be divided into salicylic acid, aniline and pyrazolone according to their chemical structure. Among them, except aniline drugs have anti-rheumatic effect, but also can treat rheumatism and rheumatoid arthritis.

Report Overview
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Product Name estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.
The USA market for Anti-Inflammatory Analgesic and Antipyretic Drugs is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The China market for Anti-Inflammatory Analgesic and Antipyretic Drugs is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The Europe market for Anti-Inflammatory Analgesic and Antipyretic Drugs is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The global key manufacturers of Anti-Inflammatory Analgesic and Antipyretic Drugs include Mallinckrodt Pharmaceuticals, IOL, Anqiu Lu'an Pharmaceutical, Novacyl, BASF, Anhui BBCA Pharmaceuticals, Hubei Biocause, Xinhua Pharm and Granules India Limited, etc. In 2021, the global top five players had a share approximately % in terms of revenue.

Report Scope
This latest report researches the industry structure, sales, revenue, price and gross margin. Major producers' production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Anti-Inflammatory Analgesic and Antipyretic Drugs manufacturers, distributors, end users, industry associations, governments' industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Anti-Inflammatory Analgesic and Antipyretic Drugs market. Further, it explains the major drivers and regional dynamics of the global Anti-Inflammatory Analgesic and Antipyretic Drugs market and current trends within the industry.

Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable sales, revenue, price, market share and rank data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
Mallinckrodt Pharmaceuticals
IOL
Anqiu Lu'an Pharmaceutical
Novacyl
BASF
Anhui BBCA Pharmaceuticals
Hubei Biocause
Xinhua Pharm
Granules India Limited
Huagang Pharm
Hebei Jiheng Pharmaceutical
Zhejiang Kangle Pharmaceutical
Hebei Jingye Medical Technology
MSPF
Lu'an Pharmaceutical
Mallinckrodt
Farmson
Anhui Fubore
SKPL
Atabay
Huzhou Konch Pharmaceutical
Anhui Topsun
SOLARA
SI Group

Market Segments
This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides sales, revenue and average price forecast data by type and by application segments based on sales, price, and value for the period 2017-2028.
Anti-Inflammatory Analgesic and Antipyretic Drugs Segment by Type
Paracetamol
Aspirin
Ibuprofen
Naproxen
Diclofenac
Oxaprozin
Dexibuprofen
Others
Anti-Inflammatory Analgesic and Antipyretic Drugs Segment by Application
Adults
Children

Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value and sales data of each region and country for the period 2017-2028.
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE

Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Anti-Inflammatory Analgesic and Antipyretic Drugs market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Report Includes:
This report presents an overview of global market for Anti-Inflammatory Analgesic and Antipyretic Drugs, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2017 - 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Anti-Inflammatory Analgesic and Antipyretic Drugs, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Anti-Inflammatory Analgesic and Antipyretic Drugs, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Anti-Inflammatory Analgesic and Antipyretic Drugs sales, revenue, market share and industry ranking of main manufacturers, data from 2017 to 2022. Identification of the major stakeholders in the global Anti-Inflammatory Analgesic and Antipyretic Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by type and by application, sales, revenue, and price, from 2017 to 2028. Evaluation and forecast the market size for Anti-Inflammatory Analgesic and Antipyretic Drugs sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Mallinckrodt Pharmaceuticals, IOL, Anqiu Lu'an Pharmaceutical, Novacyl, BASF, Anhui BBCA Pharmaceuticals, Hubei Biocause, Xinhua Pharm and Granules India Limited, etc.

Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Anti-Inflammatory Analgesic and Antipyretic Drugs in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Anti-Inflammatory Analgesic and Antipyretic Drugs manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments according to product types, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, sales and revenue for each segment.
Chapter 7: Europe by type, by application and by country, sales and revenue for each segment.
Chapter 8: Asia Pacific by type, by application and by country, sales and revenue for each segment.
Chapter 9: Latin America by type, by application and by country, sales and revenue for each segment.
Chapter 10: Middle East and Africa by type, by application and by country, sales and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Anti-Inflammatory Analgesic and Antipyretic Drugs sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（中枢神経系作用薬）の最新刊レポート

QYResearch社の医薬・ヘルスケア分野での最新刊レポート

本レポートと同じKEY WORD（analgesic）の最新刊レポート

よくあるご質問

QYResearch社はどのような調査会社ですか?

QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。 QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る

調査レポートの納品までの日数はどの程度ですか?

在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。

注文の手続きはどのようになっていますか?

1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。

お支払方法の方法はどのようになっていますか?

納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。

データリソース社はどのような会社ですか?

当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。

消炎鎮痛剤および解熱剤の世界市場に関する洞察、2028年までの予測

サマリー

目次

Summary

Table of Contents

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

本レポートと同分野（中枢神経系作用薬）の最新刊レポート

QYResearch社の医薬・ヘルスケア分野での最新刊レポート

本レポートと同じKEY WORD（analgesic）の最新刊レポート

よくあるご質問

QYResearch社はどのような調査会社ですか?

調査レポートの納品までの日数はどの程度ですか?

注文の手続きはどのようになっていますか?

お支払方法の方法はどのようになっていますか?

データリソース社はどのような会社ですか?